Clinical Trial Update: Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on chelation therapy using Pyridoxal Isonicotinoyl Hydrazone for iron overload in anemia due to beta-thalassemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Beta-thalassemia
• Iron Overload

Drugs mentioned

• Pyridoxal Isonicotinoyl Hydrazone (pyridoxal isonicotinoyl hydrazone)

Snippet

Sponsor: Case Western Reserve University | Conditions: Anemia (Iron-Loading), Beta-Thalassemia | Phase 2 | Status: COMPLETED